A critical reflection on the definition of metabolic syndrome

Pharmacological Research

Volumn 53, Issue 6, 2006, Pages 449-456

  Federspil, Giovanni ^a   Nisoli, Enzo ^b   Vettor, Roberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Definition; Epistemology; Metabolic syndrome; Obesity

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EPISTEMOLOGY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MEDICAL LITERATURE; METABOLIC SYNDROME X; METHODOLOGY; NATURAL SCIENCE; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH;

HUMANS; METABOLIC SYNDROME X; TERMINOLOGY;

EID: 33646764941     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.03.008     Document Type: Article

References (56)

1. Zimmermann JG (Von). Von der Erfahrung in der Arzneykunst. Zurich; 1763 [in German].
2. Aristotle. Topics, books I and VIII (1997), Clarendon Press, Oxford
3. Liberatore M. Compendium logicae et metaphysicae (1869), Typis Vincentii Manfredi, Neapoli
4. Mill J.S. A system of logic: ratiocinative and inductive. Being a connected view of the principles of evidence and the methods of scientific investigation. VIII ed. (1956), Longmans, Green, Reader, and Dyer, London
5. Copi M., and Cohen C. Introduction to logic (1994), The Macmillan Company, New York
6. Salmon W.C. Logic (1963), Prentice-Hall Inc., Englewood Cliffs
7. McPhee S.J., Lingappa V.R., Ganong W.F., and Lange J.D. Pathophysiology of disease. An introduction to clinical medicine (1997), Appleton and Lange, Stamford
8. Hempel C.G. Fundamentals of concept formation in empirical science (1952), The University of Chicago Press, Chicago
9. Gilardoni A. Logica e argomentazione (2005), Mimesis Edizioni, Milano [in Italian]
10. Iacona A. L'argomentazione (2005), Einaudi, Torino [in Italian]
11. Goodman, and Gilman's. The pharmacological basis of therapeutics. 9th ed. (1996), McGraw-Hill Inc., New York
12. Starling E.H. The Croonian lecture: on the chemical correlation of the functions of the body. Lancet 2 (1905) 339-341
13. Bridgman P.W. Operational analysis. Phil Sci V (1938) 114-131
14. Hempel C.G. The meaning of theoretical terms: a critique of the standard empiricist construal. In: Suppes P. (Ed). Logic, methodology and philosophy of science IV (1973), North-Holland Publishing Company, Amsterdam
15. Canguilhem G. Le normal et le pathologique (1966), Presses Universitaires de France, Paris [in French]
16. Azzone G.F. Biologia e medicina tra molecole, informazione e storia (1991), Laterza, Roma-Bari [in Italian]
17. Nordenfelt L. On the nature of health. An action-theoretic approach (1995), Kluwer Academic Publishers
18. Federspil G., Sicolo N., and Vettor R. L'esistenza delle malattie: un'analisi epistemologica. Nuova Civiltà delle Macchine 3-4 (1995) 39-47 [in Italian]
19. Grmek M.D. La vita, le malattie e la storia (1998), Di Renzo Editore, Roma [in Italian]
20. Federspil G. Logica clinica. I principi del metodo in medicina (2004), McGraw-Hill, Milano [in Italian]
21. Kylin E. Studien neber das hypertonie-hyperglykämie-hyperurikamiesyndrom. Zentralblatt fuer Innere Medizin 44 (1923) 105-127 [in German]
22. Reaven G.M. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
23. World Health Organisation. Department of Noncommunicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part I. Diagnosis and Classification of Diabetes Mellitus (1999), WHO, Geneva
24. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR). Diabet Metab 16 (1999) 442-443
25. Balkau B. Frequency of the WHO metabolic syndrome in european cohorts, and an alternative definition of an insulin resistance syndrome. Diabet Metab 28 (2002) 364-376
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Deduction, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-7.
27. Grundy S.M. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 25 (2005) 2243-2244
28. Grundy S.M., Cleemam J.I., Daniels S.R., Donato K.A., Eckel R.N., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) e285-e290
29. Grundy S.M., Cleemam J.L., Daniels S.R., Donato K.A., Eckel R.N., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Curr Opin Cardiol 21 (2006) 1-6
30. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf, accessed February 28th, 2006.
31. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 366 (2005) 1059-1062
32. Lefèbvre P.J. Prediabetes or what's in a name?. Diabetes Metab 31 (2005) 519
33. Scheen A.J., Luyckx F.H., and Lefèbvre P.J. How to explore the metabolic syndrome by its new IDF definition. Rev Med Liege 61 (2006) 48-52 [in French]
34. Kahn R., Ferrannini E., Buse J., and Stern M. The metabolic sindrome: time for a critical appraisal. Diabetes Care 28 (2005) 2289-2304
35. Nisoli E., Carruba M., and Federspil G. Replay to comment by Martìn-Làzaro and Becerra-Fernandez. Pharmacol Res 51 (2005) 387-389
36. Ferrannini E., and Balkau B. Insulin: in search of a syndrome. Diabet Med 19 (2002) 724-729
37. Mitka M. Does the metabolic syndrome really exist?. JAMA 294 (2005) 2010-2013
38. Wulff H.R. Rationel Klinik (1973), Copenhagen, Munksgaard [in Danish]
39. Various Authors: Il problema biologico della specie. Atti dell'Unione Zoologica Italiana. Modena: Mucchi Editore; 1988 [in Italian].
40. Bessey C.E. The taxonomic aspect of the species question. Am Nat 42 (1908) 218-224
41. Bernard C. Principes de médecine expérimentale (1962), Masson et Cie, Paris [in French]
42. Mc Laughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin-resistant. Ann Intern Med 139 (2003) 802-809
43. Shen B.J., Todaro J.F., Niaura R., McCaffery J.M., Zhang J., Spiro III A., et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 157 (2003) 701-711
44. Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., and Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 27 (2004) 2676-2681
45. Carr D.B., Utzschneider K.M., Hull R.L., Kodama K., Retzlaff B.M., Brunzell J.D., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53 (2004) 2087-2094
46. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., et al. Mitochondrial biogenesis in mammals: the role of endogenons nitric oxide. Science 299 (2003) 896-899
47. Nisoli E., and Carruba M. Emerging esperts of pharmacotherapy for obesity and metabolic syndrome. Pharmacol Res 50 (2004) 453-469
48. Reaven G.M. The metabolic syndrome or the insulin resistence syndrome? Different names, different conceptis, and different goals. Endocrinol Metab Clin N Am 33 (2004) 283-303
49. Reaven G. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease. The end of the beginning. Circulation 112 (2005) 3030-3032
50. Reaven G.M. Why syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab 1 (2005) 9-14
51. Reaven G.M. Just being alive is not good enough. Clin Chem 51 (2005) 1354-1357
52. Ford E.S., and Giles W.H. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26 (2003) 575-581
53. Federspil G., and Vettor R. Clinical and laboratory logic. Clin Chim Acta 280 (1999) 25-34
54. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
55. Ferrannini E. Sindrome metabolica - dalla medicina molecolare alla medicina clinica. Epidemiologia. Ann Ital Med Int 20 Suppl. 1 (2005) 445-565 [in Italian]
56. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072